UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Cable One
CABO
$205M
| $1.56M | ﹤0.01% |
4,408
+2,763
| +168% | +$1.06M |
|
4002
Group 1 Automotive
GPI
$3.17B
| $1.56M | ﹤0.01% |
5,246
-6,582
| -56% | -$1.95M |
|
|
DCBO
4003
Docebo
DCBO
$598M
| $1.56M | ﹤0.01% |
40,369
+38,004
| +1,607% | +$1.56M |
|
4004
Sturm, Ruger & Co
RGR
$596M
| $1.56M | ﹤0.01% |
37,420
+6,240
| +20% | +$277K |
|
4005
Haemonetics
HAE
$3.97B
| $1.56M | ﹤0.01% |
18,806
-39,308
| -68% | -$3.46M |
|
|
MAG
4006
DELISTED
MAG Silver
MAG
| $1.55M | ﹤0.01% |
133,236
+72,577
| +120% | +$911K |
|
4007
CALL
Packaging Corp of America
PKG
$22.9B
| $1.55M | ﹤0.01% |
8,500
-21,600
| -72% | -$3.93M |
|
4008
Equinor
EQNR
$97.3B
| $1.55M | ﹤0.01% |
54,307
+8,802
| +19% | +$245K |
|
4009
AST SpaceMobile
ASTS
$20.2B
| $1.55M | ﹤0.01% |
133,525
-62,991
| -32% | -$329K |
|
4010
BancFirst
BANF
$3.79B
| $1.55M | ﹤0.01% |
17,664
-6,145
| -26% | -$534K |
|
4011
Seacoast Banking Corp of Florida
SBCF
$3.38B
| $1.55M | ﹤0.01% |
65,499
-6,468
| -9% | -$151K |
|
|
FFC
4012
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$785M
| $1.55M | ﹤0.01% |
104,538
-2,033
| -2% | -$29.3K |
|
|
BRSL
4013
Brightstar Lottery PLC
BRSL
$2.02B
| $1.55M | ﹤0.01% |
75,562
-40,830
| -35% | -$834K |
|
4014
VanEck Video Gaming and eSports ETF
ESPO
$258M
| $1.54M | ﹤0.01% |
23,071
+7,148
| +45% | +$456K |
|
4015
State Street SPDR S&P Pharmaceuticals ETF
XPH
$509M
| $1.54M | ﹤0.01% |
38,799
-2,386
| -6% | -$96.7K |
|
4016
Viavi Solutions
VIAV
$9.34B
| $1.54M | ﹤0.01% |
224,383
-122,325
| -35% | -$951K |
|
4017
Preferred Bank
PFBC
$1.26B
| $1.54M | ﹤0.01% |
20,416
+7,687
| +60% | +$581K |
|
|
BRKL
4018
DELISTED
Brookline Bancorp
BRKL
| $1.54M | ﹤0.01% |
184,536
+22,995
| +14% | +$202K |
|
4019
CALL
Kohl's
KSS
$2.12B
| $1.54M | ﹤0.01% |
+66,900
| New | +$1.62M |
|
4020
FB Financial Corp
FBK
$3.05B
| $1.53M | ﹤0.01% |
39,304
+9,896
| +34% | +$367K |
|
|
RCS
4021
PIMCO Strategic Income Fund
RCS
$249M
| $1.53M | ﹤0.01% |
246,522
+3,516
| +1% | +$21K |
|
4022
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$919M
| $1.53M | ﹤0.01% |
137,823
-848
| -0.6% | -$9.18K |
|
4023
US Treasury 2 Year Note ETF
UTWO
$489M
| $1.53M | ﹤0.01% |
31,866
+484
| +2% | +$23.1K |
|
|
EOD
4024
Allspring Global Dividend Opportunity Fund
EOD
$287M
| $1.53M | ﹤0.01% |
314,076
+13,397
| +4% | +$63.3K |
|
4025
PUT
Xylem
XYL
$28.7B
| $1.52M | ﹤0.01% |
+11,200
| New | +$1.52M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.